Cancer is one of the biggest burdens for so many public health departments across the world and China has even more cancer patients due to growing population at rapid pace. According to GLOBCAN, nearly 2.9 Million new cancer deaths happened in China in the year 2018. If we talk about cancer incidence, this rate is much lower in China rather than United States and United Kingdom. But when we talk about mortality rate, China mortality rate is almost 30% to 40% higher than the United States and United Kingdom. According to Renub Research Analysis, China Cancer Drug Market will surpass US$ 30.5 Billion by 2025.

Access full Research:
https://www.renub.com/china-cancer-drugs-market-p.php

China cancer drug market has grown rapidly in historical period and it is expected to grow significantly during the forecast period. There are various factors that will help the market to outperform; rising ageing population in China, changes of lifestyle and food habits, rising incidence rate of several type of cancer, rise in tobacco smoking population due to expansion of urbanization in China, improving healthcare infrastructure and facilities in China, increasing per capita disposable income, rising per capita healthcare expenditure, improving awareness regarding cancer risk, potential due to emerging economies etc.

Renub Research report titled “China Cancer Drugs Market, by Drugs [Cytotoxic Drugs (Antimetabolities, Plant Alkaloids, Alkylating Agents), Targeted Drugs, Monoclonal Antibiotics, Hormonal Drugs, Traditional Chinese Medicine (TCM), & Others], Cancer (Lung, Stomach, Breast, Esophageal, Liver & Others), Therapy (Chemotherapy, Targeted Therapy, Hormonal Therapy & Others), Companies (Merck, Celgene, Eli Lilly, Roche & Sino BioPharma)” provides a complete analysis of China Anti-Cancer Drugs Market.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=china-cancer-drugs-market-p.php

By Drugs
• Cytotoxic Drugs
o Antimetabolities
o Plant Alkaloids
o Alkylating Agents
• Targeted Drugs
• Monoclonal Antibiotics
• Hormonal Drugs
• Traditional Chinese Medicine (TCM)
• Others

By Cancer
• Lung Cancer
• Stomach Cancer
• Breast Cancer
• Esophageal Cancer
• Liver Cancer
• Others

By Therapy
• Chemotherapy
• Targeted Therapy
• Hormonal Therapy
• Others

Companies Covered in the Report
• Merck
• Celegene
• Eli Lilly
• Roche
• Sino BioPharma

Request a free Brochure copy of the report: https://www.renub.com/request-brochure-page.php?gturl=china-cancer-drugs-market-p.php

If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team.

Contact Us
Email: [email protected]
Phone: +1-678-302-0700
Web: www.renub.com